GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GC81626 structure
    GC816264-Methoxyestradiol-d 5
    Purity: >98.00%

    4-Methoxyestradiol -d 5 is the deuterium labeled 4-Methoxyestradiol.

  • GC81627 structure
    GC81627ACSL5-IN-2
    CAS: 3098297-74-3
    Purity: >99.50%

    ACSL5-IN-2 is a ACSL5 inhibitor that reduces the average body weight of diet-induced obese mice.

  • GC81628 structure
    GC81628Nicotinamide- 13 C, 15 N
    Purity: >98.50%

    Nicotinamide - 13 C, 15 N (Niacinamide- 13 C, 15 N) is the 13 C- and 15 N-labeled Nicotinamide.

  • GC81629 structure
    GC81629Rabbit Hemoglobin
    Purity: >98.00%

    Rabbit Hemoglobin is a hemoglobin derived from rabbit.

  • GC81630 structure
    GC81630Mouse Hemoglobin
    Purity: >98.00%

    Mouse Hemoglobin is a hemoglobin derived from mouse.

  • GC81631 structure
    GC81631Wollastonite
    CAS: 13983-17-0
    Purity: >98.00%

    Wollastonite is a white, chain-structured pyroxene silicate mineral with biocompatibility, biodegradability, osteogenicity and antibacterial properties.

  • GC81632 structure
    GC816326-Carboxy-H2DCFDA
    CAS: 247044-02-6
    Purity: >95.00%

    6-Carboxy-H2DCFDA (6-Carboxy-2',7'-dichlorodihydrofluorescein) is a non-fluorescent, cell-permeable intracellular ROS indicator.

  • GC81633 structure
    GC81633Malonyl CoA- 13 C 3 lithium
    Purity: >99.50%

    Malonyl CoA- 13 C 3 (Malonyl coenzyme A- 13 C 3 ) lithium is the 13 C-labeled Malonyl CoA lithium.

  • GC81634 structure
    GC816342-Acetamidophenol-d 3
    CAS: 122258-87-1
    Purity: >99.00%

    2-Acetamidophenol -d 3 (Orthocetamol-d 3 ) is the deuterium labeled 2-Acetamidophenol.

  • GC81637 structure
    GC81637EBET-1593
    CAS: 3031540-97-0
    Purity: >98.00%

    EBET-1593 is a BET PROTAC degrader.

  • GC81638 structure
    GC81638PROTAC GPX4 degrader-5
    CAS: 3119292-91-7
    Purity: >95.00%

    PROTAC GPX4 degrader-5 (compound N15) is an efficient and highly selective PROTAC GPX4 degrader ( DC 50 = 28 nM).

  • GC81639 structure
    GC81639SH-26
    Purity: >98.00%

    SH-26 is a PHD1 PROTAC degrader with DC 50 s of 1.06 μM, 4.16 μM and 4.91 μM in MDA-MB-231, HepG2 and HEK-293T cells, respectively.

  • GC81640 structure
    GC81640LXH-3-71
    CAS: 2251753-65-6
    Purity: >97.00%

    LXH-3-71 is a PHGDH degrader.

  • GC81641 structure
    GC81641FQI2-34
    CAS: 2762499-38-5
    Purity: >99.50%

    FQI2-34 is an orally active TFCP2 (LSF) small molecule allosteric inhibitor.

  • GC81642 structure
    GC81642NR2F6 modulator-2
    CAS: 22978-55-8
    Purity: >99.00%

    NR2F6 modulator-2 (Compound I) is an autorepressed orphan nuclear receptor NR2F6 (Nuclear Receptor subfamily 2 group F member 6) modulator.

  • GC81643 structure
    GC81643RJW103
    CAS: 1276664-14-2
    Purity: >98.50%

    RJW103 is an acid-stable SF-1 (NR5A1) and LRH-1 agonist with pEC 50 values of 6.5 and 5.9, respectively.

  • GC81645 structure
    GC81645CKGGRAKDC (linear) TFA
    Purity: >96.50%

    CKGGRAKDC (linear) TFA is an adipose tissue homing peptide.

  • GC81646 structure
    GC81646DTLMISR acetate
    Purity: >98.00%

    DTLMISR acetate is a tryptic peptide widely present in the Fc regions of all four human IgG subclasses.

  • GC81654 structure
    GC816542-5A TEA
    CAS: 72351-33-8
    Purity: >98.00%

    2-5A TEA (2′,5′-ApApA TEA) is a 5'-triphosphorylated (2',5') oligoadenylate.

  • GC81655 structure
    GC81655Poly(A) polymerase
    CAS: 9026-30-6
    Purity: >98.00%

    Poly(A) polymerase catalyzes the incorporation of ATP into the RNA 3' end in the form of AMP, that is, adding a polyadenosine tail at the RNA 3' end.

  • GC81656 structure
    GC81656DNA-GAGA
    CAS: 110138-50-6
    Purity: >98.00%

    DNA-GAGA is a slow substrate for Ricin toxin A-chain (RTA).

  • GC81657 structure
    GC816573'-Fluorothymidine-5'-triphosphate tetrasodium
    CAS: 1443116-39-9
    Purity: >99.50%

    3'-Fluorothymidine-5'-triphosphate tetrasodium (3'-FdTTP tetrasodium) is a dTTP analog.

  • GC81658 structure
    GC81658FAM-hsa-miR-147b-5p mimic
    Purity: >98.00%

    FAM-hsa-miR-147b-5p mimic is a FAM-labeled hsa-miR-147b-5p mimic.

  • GC81659 structure
    GC81659GAPDH Positive Control siRNA (Human)
    Purity: >98.00%

    GAPDH Positive Control siRNA (Human), a siRNA product, is a human GAPDH siRNA positive control.